1,2,4-triazole has been researched along with Disease Models, Animal in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abruzzo, GK; Apgar, JM; Balkovec, JM; Dragovic, J; Fan, W; Flattery, AM; Galgoci, AM; Giacobbe, RA; Gill, CJ; Greenlee, ML; Hsu, MJ; Kahn, JN; Kirwan, R; Lee, S; Liberator, P; Liu, H; Mamai, A; Meng, D; Misura, AS; Motyl, M; Nelson, K; Parker, DL; Peel, M; Powles, M; Racine, F; Sperbeck, D; Wildonger, KJ; Wilkening, RR | 1 |
Gryboś, A; Głuch-Lutwin, M; Jóźwiak, K; Kaproń, B; Karcz, T; Mordyl, B; Nowak, G; Pająk, K; Paneth, A; Plech, T; Siwek, A; Tomczykowski, A; Wujec, M; Łuszczki, J | 1 |
Ahmed, EA; Mekheimer, RA; Sadek, KU; Sayed, AA | 1 |
Alam, MM; Alam, MS; Haider, S; Hamid, H; Nazreen, S; Shafi, S; Yar, MS | 1 |
Garigipati, S; Kundu, B; Semwal, A; Sharma, M; Sriram, D; Vanamala, D; Yogeeswari, P | 1 |
5 other study(ies) available for 1,2,4-triazole and Disease Models, Animal
Article | Year |
---|---|
MK-5204: An orally active β-1,3-glucan synthesis inhibitor.
Topics: Administration, Oral; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Disease Models, Animal; Glucosyltransferases; Glycosides; Half-Life; Mice; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship; Triazoles; Triterpenes | 2020 |
Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electroshock; Hep G2 Cells; Humans; Mice; Patch-Clamp Techniques; Seizures; Thiones; Triazoles; Voltage-Gated Sodium Channels | 2017 |
Synthesis and Characterization of New 1,2,4-Triazolo[1,5-a]pyridines That Extend the Life Span of Caenorhabiditis elegans via Their Anti-Inflammatory/Antioxidant Effects.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biphenyl Compounds; Caenorhabditis elegans; Carrageenan; Dextrans; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Edema; Glycation End Products, Advanced; Glycosylation; Heat-Shock Response; Longevity; Male; Molecular Structure; Oxidative Stress; Picrates; Pyridines; Rats; Structure-Activity Relationship; Time Factors; Triazoles | 2015 |
Synthesis of some new s-alkylated 1,2,4-triazoles, their mannich bases and their biological activities.
Topics: Analgesics; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Disease Models, Animal; Female; Ibuprofen; Male; Mannich Bases; Microbial Sensitivity Tests; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles | 2012 |
Discovery of novel 1,2,4-triazol-5-ones as tumor necrosis factor-alpha inhibitors for the treatment of neuropathic pain.
Topics: Analgesics; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Edema; Humans; Mice; Neuralgia; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles; Tumor Necrosis Factor-alpha | 2012 |